Hadasit Medical Research Services AND Development Ltd.
USPTO PatentsView assignee record - 106 granted patents across 37 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).
The verdict
According to USPTO PatentsView, Hadasit ranks #3,478 of 49,997 tracked US assignees by granted-patent volume, with 106 patents across 37 technology areas.
- #3,478
- of 49,997 US assignees by volume
- Top 13%
- by Innovation Score (50.5/100)
- 14.5
- avg claims per patent
- -21%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R3478 · Foreign Corporation #3,478 · 106 grants
GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL
- GRANTS-MID 106 grants
- TOP-DECILE #3,478/49,997
- PHOTO-FINISH Colorado School of…
- CPC-FOCUS A61K · 37 areas
- INNOV-PAR 50.5/100
- CLAIMS-RICH 14.5 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-DOWN -21% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Colorado School of Mines (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Hadasit’s 50.5 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Hadasit
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Fuji Jukogyo · near
Fuji Jukogyo · near
50 score
- Hadasit Medical… · this assignee
Hadasit Medical… · this assignee
50 score
- Luminar · near
Luminar · near
50 score
- Repsol · near
Repsol · near
50 score
- Watergen · near
Watergen · near
50 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Hadasit's Innovation Score is 50.5/100 (top 13% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Hadasit?
Each dot is one of Hadasit’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Hadasit’s own 14.5 claims/patent is at or below the 17.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Hadasit's grants concentrate
Hadasit Medical Research Services AND Development Ltd. is a focused PatentsView assignee: 37 CPC subclasses with 75.5% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2019 (16 grants) versus a trough of 5 in 2024. By volume, Hadasit sits between Colorado School of Mines and Shenzhen Yinwang Intelligent Technologies Co., Ltd..
Hadasit's three-year grant acceleration
From 2019–2021 to 2022–2024, Hadasit Medical Research Services AND Development Ltd. moved from 37 to 23 grants (0.62x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,384. See the growth leaderboard.
Who files at Hadasit's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Colorado School o…
Colorado School of Mines
106 patents
- FCI USA
FCI USA LLC
106 patents
- Festool
Festool GMBH
106 patents
- Fujifilm Material…
Fujifilm Electronic Materials U.S.A., Inc.
106 patents
- Indian Institute…
Indian Institute OF Technology Madras (IIT MADRAS)
106 patents
- Lupin
Lupin Limited
106 patents
- Poet Research
Poet Research, Inc.
106 patents
- Shenzhen Yinwang…
Shenzhen Yinwang Intelligent Technologies Co., Ltd.
106 patents
- Hadasit Medical R… ◀
Hadasit Medical Research Services AND Development Ltd.
106 patents
What this shows Hadasit holds 106 patents at rank #3,478, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Hadasit
By rank, the assignees closest to #3,478 in granted patent volume.
- Colorado School of Mines #3,474 · 106 patents
- FCI USA LLC #3,475 · 106 patents
- Festool GMBH #3,476 · 106 patents
- Fujifilm Electronic Materials U.S.A., Inc. #3,477 · 106 patents
- Indian Institute OF Technology Madras (IIT MADRAS) #3,479 · 106 patents
- Lupin Limited #3,480 · 106 patents
- Poet Research, Inc. #3,481 · 106 patents
- Shenzhen Yinwang Intelligent Technologies Co., Ltd. #3,482 · 106 patents
Leaders in A61K (Preparations FOR Medical)
Other assignees with the most granted patents in Hadasit's primary technology class.
- The Regents of the University of California 1,779 in class
- L'Oreal 1,250 in class
- Novartis AG 988 in class
- The Procter & Gamble Company 985 in class
- The Board of Regents of the University of Texas System 950 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 813 in class
- The Trustees of the University of Pennsylvania 768 in class
- Merck Sharp & Dohme LLC 760 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Hadasit, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Hadasit ranks #242 of 7,163 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (50 here).
Similar claim depth
Nearest assignees by average claims per patent (14.5 here).
Hadasit's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
50 Top 13% higher than 87% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 12 | 11.3% |
| 2016 | 10 | 9.4% |
| 2017 | 6 | 5.7% |
| 2018 | 12 | 11.3% |
| 2019 | 16 | 15.1% |
| 2020 | 9 | 8.5% |
| 2021 | 12 | 11.3% |
| 2022 | 9 | 8.5% |
| 2023 | 9 | 8.5% |
| 2024 | 5 | 4.7% |
| 2025partial year | 6 | 5.7% |
Which technologies does Hadasit Medical Research Services AND Development Ltd. patent most?
Top 15 of 37 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Hadasit Medical Research Services AND Development Ltd.'s patent record in context - here's where to go next.
- Hadasit Medical Research Services AND Development Ltd.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 75.5% of its portfolio - see every assignee active in that class. Explore A61K
- Ranked #3,478 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Hadasit Medical Research Services AND Development Ltd. against Colorado School of Mines, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 50.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.